Drug intelligence / Profile preview

bufei yishen fang

Development stage
Preclinical
Administration
Oral
01

Overview

Bufei Yishen Fang (BYF), also known as Bufei Yishen formula, is a patented (No. ZL.201110117578.1) traditional Chinese medicine (TCM) formula used to treat chronic obstructive pulmonary disease (COPD). It consists of twelve medicinal herbs and is administered orally, often as granules. According to TCM principles, it is designed to tonify the lung and kidney, resolve phlegm, and promote blood circulation. Clinical studies and meta-analyses suggest it can reduce the frequency of exacerbations, improve lung function (FEV1), enhance exercise capacity (6-minute walk test), and improve quality of life (CAT scores) in patients with stable COPD, often in combination with conventional Western medicine. [1, 2, 3, 4] Its mechanism of action is multifactorial, involving the suppression of inflammatory cytokine expression (such as IL-17 and TNF-α), protection of the airway epithelial barrier, regulation of the protease-antiprotease balance, and enhancement of autophagy through the Sirt1/AMPK/Foxo3 signaling pathway. [1, 4]

Other names
Bufei Yishen formulaBufei Yishen granulesBFYS granulesBushen Yifei Decoction
02

Targets

HIF1A (Hypoxia-inducible factor 1-alpha)

Beyond the preview

Go deeper on bufei yishen fang.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on bufei yishen fang.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call